Back to Trades
Golumbeski George
DirectorCIK 0001586660
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 4
- Active
- 2025–2026
Golumbeski George, Director, has filed 7 SEC reports (2025–2026), spread across 4 companies, totaling $1.0M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Jun 5 | ABOS Acumen Pharmaceuticals, Inc. | Golumbeski George | Director | Grant | $121.9K |
| Jun 2 | STTK Shattuck Labs, Inc. | Golumbeski George | Insider | Award | $481.9K |
| Dec 5 | MURA Mural Oncology plc | Golumbeski George | Insider | Disposed | $73.9K |
| Nov 10 | ABOS Acumen Pharmaceuticals, Inc. | Golumbeski George | Director | Award | $95.0K |
| Nov 10 | ABOS Acumen Pharmaceuticals, Inc. | Golumbeski George | Director | Other | $0 |
| Jul 31 | SAGE Sage Therapeutics, Inc. | Golumbeski George | Insider | Disposed | $229.0K |
| Jul 16 | STTK Shattuck Labs, Inc. | Golumbeski George | Insider | Award | $27.2K |
7 filings